Table 1

Enrichment of SNPs predisposing to immune-mediated diseases within HMRs

GWASNo. of associated SNPsHMRCell-type–specific HMR*
CD4CD8CD14CD16CD19PBMCCD4CD8CD14CD16CD19
Crohn's disease 70 30 30 33 32 29 28 12 (1) 9 (2) 10 11 12 (1) 
Primary biliary cirrhosis 20 10 10 11 11 10 2 2 4 
T1D 64 25 24 23 24 24 22 6 (2) 6 (1) 6 (1) 
Ulcerative colitis 45 16 15 17 16 16 14 4 (1) 5 (1) 
GWASNo. of associated SNPsHMRCell-type–specific HMR*
CD4CD8CD14CD16CD19PBMCCD4CD8CD14CD16CD19
Crohn's disease 70 30 30 33 32 29 28 12 (1) 9 (2) 10 11 12 (1) 
Primary biliary cirrhosis 20 10 10 11 11 10 2 2 4 
T1D 64 25 24 23 24 24 22 6 (2) 6 (1) 6 (1) 
Ulcerative colitis 45 16 15 17 16 16 14 4 (1) 5 (1) 
*

HMRs that specifically occur in the given cell type (see “Methods”); values in parentheses indicate number of SNPs within the subset rHMRs (i.e., those associated with a change in gene expression).

P < .0001.

Close Modal

or Create an Account

Close Modal
Close Modal